VANCOUVER, BC – WEX Pharmaceuticals Inc. (“WEX” or the “Company”), a clinical-stage biotechnology company developing Halneuron® (Tetrodotoxin or TTX) for pain, is pleased to announce the presentation of a scientific… Read More
Eligible transfusion-dependent beta thalassemia (TDT) patients in England will be able to access the therapy from today CASGEVY is one of the first medicines funded by NHS England’s Innovative Medicines… Read More
Three Canadian scientists have been recognized by UBC’s Faculty of Medicine for their exceptional scientific achievements in the areas of cancer, brain health and heart disorders. Dr. Cheryl Arrowsmith, Dr…. Read More
Nipocalimab delayed or prevented severe fetal anemia and 54 percent of study participants in the Phase 2 UNITY study achieved a live birth at or after 32 weeks without the… Read More
VANCOUVER, BC – Gandeeva Therapeutics leadership and staff were saddened to learn of Don Kania’s passing on July 28, 2024. Don, pictured above, was a dear ally, advisor, and colleague…. Read More
